Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (44)Baxfendy approved in the US for hypertension
Preheader (119)Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
Typography
Arial
Colors
Text Analysis
Body Words129
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px734 px
X-Spam Score-0.5
Preheader OptimizedNo
Timing
Day of WeekTuesday
TimeAfternoon

Baxfendy approved in the US for hypertension

Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
Baxfendy approved in the US for hypertension